159 related articles for article (PubMed ID: 21097610)
21. First report of a cross-kingdom pathogenic bacterium, Achromobacter xylosoxidans isolated from stipe-rot Coprinus comatus.
Ye L; Guo M; Ren P; Wang G; Bian Y; Xiao Y; Zhou Y
Microbiol Res; 2018 Mar; 207():249-255. PubMed ID: 29458861
[TBL] [Abstract][Full Text] [Related]
22. Genome sequence of the highly efficient arsenite-oxidizing bacterium Achromobacter arsenitoxydans SY8.
Li X; Hu Y; Gong J; Lin Y; Johnstone L; Rensing C; Wang G
J Bacteriol; 2012 Mar; 194(5):1243-4. PubMed ID: 22328747
[TBL] [Abstract][Full Text] [Related]
23. AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand.
Pongchaikul P; Santanirand P; Antonyuk S; Winstanley C; Darby AC
FEMS Microbiol Lett; 2020 Jul; 367(14):. PubMed ID: 32592387
[TBL] [Abstract][Full Text] [Related]
24. Complete genome sequence of Nitrosospira multiformis, an ammonia-oxidizing bacterium from the soil environment.
Norton JM; Klotz MG; Stein LY; Arp DJ; Bottomley PJ; Chain PS; Hauser LJ; Land ML; Larimer FW; Shin MW; Starkenburg SR
Appl Environ Microbiol; 2008 Jun; 74(11):3559-72. PubMed ID: 18390676
[TBL] [Abstract][Full Text] [Related]
25. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
[TBL] [Abstract][Full Text] [Related]
26. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.
Magni A; Trancassini M; Varesi P; Iebba V; Curci A; Pecoraro C; Cimino G; Schippa S; Quattrucci S
J Clin Microbiol; 2010 Apr; 48(4):1035-9. PubMed ID: 20107101
[TBL] [Abstract][Full Text] [Related]
27. Complete genome sequence of Acidovorax sp. strain KKS102, a polychlorinated-biphenyl degrader.
Ohtsubo Y; Maruyama F; Mitsui H; Nagata Y; Tsuda M
J Bacteriol; 2012 Dec; 194(24):6970-1. PubMed ID: 23209225
[TBL] [Abstract][Full Text] [Related]
28. Biodegradation and detoxification of endosulfan in aqueous medium and soil by Achromobacter xylosoxidans strain CS5.
Li W; Dai Y; Xue B; Li Y; Peng X; Zhang J; Yan Y
J Hazard Mater; 2009 Aug; 167(1-3):209-16. PubMed ID: 19237238
[TBL] [Abstract][Full Text] [Related]
29. Elucidation of fluoranthene degradative characteristics in a newly isolated Achromobacter xylosoxidans DN002.
Ma YL; Lu W; Wan LL; Luo N
Appl Biochem Biotechnol; 2015 Feb; 175(3):1294-305. PubMed ID: 25381650
[TBL] [Abstract][Full Text] [Related]
30. Achromobacter Infection Is Rare in Japanese Patients with Pulmonary B-cell Lymphoma.
Aoyama S; Masaki A; Sakamoto Y; Takino H; Murase T; Ohshima K; Yoshino T; Kato S; Inagaki H
Intern Med; 2018 Mar; 57(6):789-794. PubMed ID: 29151525
[TBL] [Abstract][Full Text] [Related]
31. Characterization of pbt genes conferring increased Pb2+ and Cd2+ tolerance upon Achromobacter xylosoxidans A8.
Hložková K; Suman J; Strnad H; Ruml T; Paces V; Kotrba P
Res Microbiol; 2013 Dec; 164(10):1009-18. PubMed ID: 24125695
[TBL] [Abstract][Full Text] [Related]
32. Complete genome sequence of the chloromethane-degrading Hyphomicrobium sp. strain MC1.
Vuilleumier S; Nadalig T; Ul Haque MF; Magdelenat G; Lajus A; Roselli S; Muller EE; Gruffaz C; Barbe V; Médigue C; Bringel F
J Bacteriol; 2011 Sep; 193(18):5035-6. PubMed ID: 21868803
[TBL] [Abstract][Full Text] [Related]
33. Genomic and phylogenetic analysis of multidrug-resistant Achromobacter xylosoxidans ST273 strain MTYH1 co-carrying bla
Zhu Z; Xu J; He F
J Glob Antimicrob Resist; 2021 Jun; 25():110-113. PubMed ID: 33766786
[TBL] [Abstract][Full Text] [Related]
34. Interspecies Dissemination of a Mobilizable Plasmid Harboring blaIMP-19 and the Possibility of Horizontal Gene Transfer in a Single Patient.
Yamamoto M; Matsumura Y; Gomi R; Matsuda T; Tanaka M; Nagao M; Takakura S; Uemoto S; Ichiyama S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5412-9. PubMed ID: 27381397
[TBL] [Abstract][Full Text] [Related]
35. Uncommon pathogen: Serious manifestation: A rare case of Achromobacter xylosoxidans septic arthritis in immunocompetetant patient.
Suryavanshi KT; Lalwani SK
Indian J Pathol Microbiol; 2015; 58(3):395-7. PubMed ID: 26275277
[TBL] [Abstract][Full Text] [Related]
36. Why two are not enough: degradation of p-toluenesulfonate by a bacterial community from a pristine site in Moorea, French Polynesia.
Tralau T; Yang EC; Tralau C; Cook AM; Küpper FC
FEMS Microbiol Lett; 2011 Mar; 316(2):123-9. PubMed ID: 21204940
[TBL] [Abstract][Full Text] [Related]
37. Statistically optimized ceftriaxone sodium biotransformation through Achromobacter xylosoxidans strain Cef6: an unusual insight for bioremediation.
Anan A; Ghanem KM; Embaby AM; Hussein A; El-Naggar MY
J Basic Microbiol; 2018 Feb; 58(2):120-130. PubMed ID: 29141102
[TBL] [Abstract][Full Text] [Related]
38. Imipenem-resistant Achromobacter xylosoxidans carrying blaVIM-2-containing class 1 integron.
Shin KS; Han K; Lee J; Hong SB; Son BR; Youn SJ; Kim J; Shin HS
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):215-20. PubMed ID: 16260111
[TBL] [Abstract][Full Text] [Related]
39. The genome of Polaromonas sp. strain JS666: insights into the evolution of a hydrocarbon- and xenobiotic-degrading bacterium, and features of relevance to biotechnology.
Mattes TE; Alexander AK; Richardson PM; Munk AC; Han CS; Stothard P; Coleman NV
Appl Environ Microbiol; 2008 Oct; 74(20):6405-16. PubMed ID: 18723656
[TBL] [Abstract][Full Text] [Related]
40. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients.
Raso T; Bianco O; Grosso B; Zucca M; Savoia D
APMIS; 2008 Sep; 116(9):837-41. PubMed ID: 19024606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
